Evidence map›Paper›PMID 25662604›Full record

ArticleNucleic acids research2015

MicroRNA-26a induced by hypoxia targets HDAC6 in myogenic differentiation of embryonic stem cells.

Sae-Won Lee, Jimin Yang, Su-Yeon Kim, Han-Kyul Jeong, Jaewon Lee, Woo Jean Kim, Eun Ju Lee, Hyo-Soo Kim

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Tubulin Acetylation: A Critical Regulator of Microtubule Function.Results and problems in cell differentiation · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Fungal Extracellular Vesicles in Pathophysiology.Sub-cellular biochemistry · 2021
    Article
  12. Inhibition ofFrontiers in cell and developmental biology · 2021
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sae-Won LeeDepartment of Internal Medicine and Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul, Korea Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
Jimin YangDepartment of Internal Medicine and Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul, Korea.
Su-Yeon KimDepartment of Internal Medicine and Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul, Korea.
Han-Kyul JeongDepartment of Internal Medicine and Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul, Korea.
Jaewon LeeDepartment of Internal Medicine and Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul, Korea.
Woo Jean KimNational Research Laboratory of Regenerative Sexual Medicine, Department of Urology, Inha University School of Medicine, Incheon, Korea.
Eun Ju LeeDepartment of Internal Medicine and Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul, Korea Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
Hyo-Soo KimDepartment of Internal Medicine and Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul, Korea Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea hyosoo@snu.ac.kr.
Seoul National University Hospital · KRInha University · KRSeoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The importance of epigenetic regulation for maintenance of embryonic stem cell (ESC) pluripotency or for initiation of differentiation is widely accepted. However, the molecular mechanisms are poorly understood. We recently reported that a hypoxic microenvironment induces ESC differentiation. In the present study, we found that hypoxia-responsive histone deacetylase 6 (HDAC6) performs an essential signaling function for myogenic differentiation of ESCs. HDAC6 was downregulated in hypoxic ESCs or during differentiation. A knock-down of HDAC6 in ESCs resulted in induction of myogenic markers, including Pax7. Suppression of HDAC6 increased acetylation of core histones H3 and H4, leading to enhanced binding of RNA polymerase II to the Pax7 promoter. Transplantation of HDAC6 knock-down cells facilitated muscle regeneration in vivo. Importantly, the downregulation of HDAC6 by hypoxia was not mediated by HIF1α or HIF2α, master transcription regulators under hypoxia, but by induction of microRNA-26a that directly targeted the 3'-untranslated region (3'-UTR) of HDAC6. A point mutation of the microRNA-26a-binding sequence in the HDAC6 3'-UTR diminished the luciferase reporter activity. Taken together, these results suggest that environmental cues of differentiation modulate the epigenetic machinery and guide stem cells to commit to a specific lineage.

Indexed as

Epigenesis, GeneticAnimalsCell HypoxiaCell LineageCells, CulturedDown-RegulationEmbryonic Stem CellsHistone Deacetylase 6Histone DeacetylasesMaleMesodermMice, Inbred C57BLMicroRNAsMuscle DevelopmentMuscle, SkeletalPAX7 Transcription FactorHdac6 protein, mouseHistone Deacetylase 6Histone DeacetylasesMicroRNAsMirn26 microRNA, mousePAX7 Transcription Factor

Identifiers

PMID25662604
PMCPMC4344521
OpenAlexW2047686177

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.